207 related articles for article (PubMed ID: 24015287)
1. LRRK2 and RIPK2 variants in the NOD 2-mediated signaling pathway are associated with susceptibility to Mycobacterium leprae in Indian populations.
Marcinek P; Jha AN; Shinde V; Sundaramoorthy A; Rajkumar R; Suryadevara NC; Neela SK; van Tong H; Balachander V; Valluri VL; Thangaraj K; Velavan TP
PLoS One; 2013; 8(8):e73103. PubMed ID: 24015287
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis of leprosy by using a multiplex branched DNA assay.
Sun Y; Liu H; Yu G; Chen X; Liu H; Tian H; Zhou G; Zhang F
Exp Dermatol; 2011 Jun; 20(6):520-2. PubMed ID: 21585556
[TBL] [Abstract][Full Text] [Related]
3. Allele-dependent interaction of LRRK2 and NOD2 in leprosy.
Dallmann-Sauer M; Xu YZ; da Costa ALF; Tao S; Gomes TA; Prata RBDS; Correa-Macedo W; Manry J; Alcaïs A; Abel L; Cobat A; Fava VM; Pinheiro RO; Lara FA; Probst CM; Mira MT; Schurr E
PLoS Pathog; 2023 Mar; 19(3):e1011260. PubMed ID: 36972292
[TBL] [Abstract][Full Text] [Related]
4. Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China.
Wang D; Xu L; Lv L; Su LY; Fan Y; Zhang DF; Bi R; Yu D; Zhang W; Li XA; Li YY; Yao YG
Genes Immun; 2015 Mar; 16(2):112-9. PubMed ID: 25521227
[TBL] [Abstract][Full Text] [Related]
5. LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation.
Yan R; Liu Z
Protein Cell; 2017 Jan; 8(1):55-66. PubMed ID: 27830463
[TBL] [Abstract][Full Text] [Related]
6. Genomewide association study of leprosy.
Netea MG; Kullberg BJ; van der Meer JW
N Engl J Med; 2010 Apr; 362(15):1447; author reply 1447-8. PubMed ID: 20397292
[No Abstract] [Full Text] [Related]
7. Association of NOD2 and IFNG single nucleotide polymorphisms with leprosy in the Amazon ethnic admixed population.
Leturiondo AL; Noronha AB; Mendonça CYR; Ferreira CO; Alvarado-Arnez LE; Manta FSN; Bezerra OCL; Carvalho EF; Moraes MO; Rodrigues FDC; Talhari C
PLoS Negl Trop Dis; 2020 May; 14(5):e0008247. PubMed ID: 32433683
[TBL] [Abstract][Full Text] [Related]
8. A Missense LRRK2 Variant Is a Risk Factor for Excessive Inflammatory Responses in Leprosy.
Fava VM; Manry J; Cobat A; Orlova M; Van Thuc N; Ba NN; Thai VH; Abel L; Alcaïs A; Schurr E;
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004412. PubMed ID: 26844546
[TBL] [Abstract][Full Text] [Related]
9. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy.
Zhang F; Liu H; Chen S; Low H; Sun L; Cui Y; Chu T; Li Y; Fu X; Yu Y; Yu G; Shi B; Tian H; Liu D; Yu X; Li J; Lu N; Bao F; Yuan C; Liu J; Liu H; Zhang L; Sun Y; Chen M; Yang Q; Yang H; Yang R; Zhang L; Wang Q; Liu H; Zuo F; Zhang H; Khor CC; Hibberd ML; Yang S; Liu J; Zhang X
Nat Genet; 2011 Oct; 43(12):1247-51. PubMed ID: 22019778
[TBL] [Abstract][Full Text] [Related]
10. [The genetic susceptibility to leprosy in humans].
Lagrange PH; Abel L
Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289
[TBL] [Abstract][Full Text] [Related]
11. Genomewide association study of leprosy.
Wong SH; Hill AV; Vannberg FO;
N Engl J Med; 2010 Apr; 362(15):1446-7; author reply 1447-8. PubMed ID: 20393182
[No Abstract] [Full Text] [Related]
12. Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer.
Guirado M; Gil H; Saenz-Lopez P; Reinboth J; Garrido F; Cozar JM; Ruiz-Cabello F; Carretero R
Hum Immunol; 2012 Jun; 73(6):668-72. PubMed ID: 22504414
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
Hrdinka M; Schlicher L; Dai B; Pinkas DM; Bufton JC; Picaud S; Ward JA; Rogers C; Suebsuwong C; Nikhar S; Cuny GD; Huber KV; Filippakopoulos P; Bullock AN; Degterev A; Gyrd-Hansen M
EMBO J; 2018 Sep; 37(17):. PubMed ID: 30026309
[TBL] [Abstract][Full Text] [Related]
14. Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states.
Berrington WR; Macdonald M; Khadge S; Sapkota BR; Janer M; Hagge DA; Kaplan G; Hawn TR
J Infect Dis; 2010 May; 201(9):1422-35. PubMed ID: 20350193
[TBL] [Abstract][Full Text] [Related]
15. Crohn's disease susceptibility genes are associated with leprosy in the Vietnamese population.
Grant AV; Alter A; Huong NT; Orlova M; Van Thuc N; Ba NN; Thai VH; Abel L; Schurr E; Alcais A
J Infect Dis; 2012 Dec; 206(11):1763-7. PubMed ID: 22984114
[TBL] [Abstract][Full Text] [Related]
16. Association of the rs2111234, rs3135499, rs8057341 polymorphisms in the NOD2 gene with leprosy: A case-control study in the Norte de Santander, Colombia population.
Bustos MA; Castañeda-Castañeda LD; Acosta CR; García D; Bohada DP; Rodríguez R; Guerrero MI
PLoS One; 2023; 18(3):e0281553. PubMed ID: 36877680
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the role of LRRK2 gene in Parkinson's disease in an East Indian cohort.
Sadhukhan T; Vishal M; Das G; Sharma A; Mukhopadhyay A; Das SK; Ray K; Ray J
Dis Markers; 2012; 32(6):355-62. PubMed ID: 22684232
[TBL] [Abstract][Full Text] [Related]
18. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome.
Cardoso CC; Pereira AC; de Sales Marques C; Moraes MO
Future Microbiol; 2011 May; 6(5):533-49. PubMed ID: 21585261
[TBL] [Abstract][Full Text] [Related]
19. Absence of nucleotide-binding oligomerization domain-containing protein 2 variants in patients with leprosy and tuberculosis.
Singh V; Gaur R; Mittal M; Biswas SK; Das R; Girdhar BK; Bajaj B; Katoch VM; Kumar A; Mohanty KK
Int J Immunogenet; 2012 Aug; 39(4):353-6. PubMed ID: 22289211
[TBL] [Abstract][Full Text] [Related]
20. Leprosy as a genetic disease.
Alter A; Grant A; Abel L; Alcaïs A; Schurr E
Mamm Genome; 2011 Feb; 22(1-2):19-31. PubMed ID: 20936290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
